Benzodiazepine bromodomain inhibitor

Details for Australian Patent Application No. 2010317096 (hide)

Owner GlaxoSmithKline LLC

Inventors Bailey, James; Gosmini, Romain Luc Marie; Mirguet, Olivier; Witherington, Jason

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010317096

PCT Pub. Number WO2011/054845

Priority 0919433.3 05.11.09 GB; 1010509.6 22.06.10 GB; 1014231.3 25.08.10 GB; PCT/ EP2010/061518 06.08.10 EP

Filing date 3 November 2010

Wipo publication date 12 May 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

31 May 2012 PCT application entered the National Phase

  PCT publication WO2011/054845 Priority application(s): WO2011/054845

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010317139-Composition comprising cells and a polyunsaturated fatty acid having at least 20 carbon atoms (LC-PUFA)

2010317085-Benzimidazole-imidazole derivatives